Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker      Tax Corner NRI Centre Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Wipro Lt 559.50 3.82
Tata Stl 458.95 0.40
Tata Pow 88.00 0.28
Ong Corp 403.25 0.80
Hindalco 149.65 0.81
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-Nectar Lifesciences Limited
Nectar Lifesciences Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs and Formulations
BSE:532649NSE:NECLIFEBloomberg:NLSC@INReuters:NECT.BO
Market Lot: 1Face Value: 1ISIN Demat: INE023H01027
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
11-JUN-14 Nectar Lifesciences (NecLife) announced that it has received second European cGMP (Current Good Manufacturing Practices) approval for its Cephalasporin Finished Dosage Forms (FDF) manufacturing facility in Baddi, Himachal Pradesh. 08-DEC-11 Nectar Lifesciences, a fast growing manufacturer of generic active pharmaceutical ingredients (APIs) and Formulation products has achieved yet another significant milestone by receiving European c...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Nectar Lifesciences gets European cGMP approval  -IRIS 11-Jun-14
Previous

More


Brief Financials (in Rs. Mn.) 
Period ending (months)30-Jun-2014(3)31-Mar-2014 (12)31-Mar-2013 (12)
Net sales 3815.7816377.6916248.14
Other Income23.02116.28160.40
Total Income3838.8016493.9716408.54
Cost of goods sold3159.8213495.4413361.70
OPBDIT678.982998.533046.84
PAT162.50620.80856.66
Gross Block---
Equity capital224.26224.26224.26
EPS (Rs.)-2.773.82
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-3.48 - 9.123.94 - 6.79
Debt / Equity (x)---
Operating margin (% of OI)17.718.218.6
Net margin (% of OI) 4.2 3.8 5.2
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
Village Saidpura
Tehsil Derabassi
S A S Nagar
Mohali
Punjab-- - -
PHONE
(01762) 3080 00/ 01
FAX
(01762) 2811 87
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer